Definium Therapeutics, Up 190% This Year, Succeeds Again With LSD; Shares Fly
Key Points:
- Investor’s Business Daily (IBD) provides information for educational purposes and does not offer investment advice or recommendations to buy or sell securities.
- The information is sourced from what IBD believes are reliable sources, but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance shared by IBD does not predict or ensure future results.
- Authors and presenters may hold stocks they discuss, and IBD does not warranty the advisability of any investment or strategy.
- Real-time price data is provided by Nasdaq Last Sale, ownership data by LSEG, and estimates by FactSet, with trademarks owned by Investor’s Business Daily, LLC.